Product Information

DILTIAZEM 12HR ER 120 MG CAP is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $1.9794 per EA under NDC 68462056201. Its NADAC has been published 280 times since Apr 14, 2021.

FDA first approved this application on Mar 22, 2021. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILTIAZEM 12HR ER 120 MG CAP

Diltiazem Hydrochloride
$1.9794per EA

Strength

120 mg/1

NDC

68462056201

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA212317

FDA Approved

3/22/2021

TE Code

AB1

On Market Since

3/22/2021

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for DILTIAZEM 12HR ER 120 MG CAP has been published 280 times since Apr 14, 2021, and over the history we have for it it has declined 44.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.9794 per EA
All-time high$3.9505 (Sep 13, 2023)
All-time low$1.4219 (Jul 17, 2024)
52-week high$2.5115
52-week low$1.9794
Median price$3.0526
Average price$2.9555
Largest weekly change-50.4% (Apr 17, 2024)
Weeks tracked280
Tracking sinceApr 14, 2021

Price History

1W

-4.3%

1M

-8.2%

3M

-11.2%

6M

-19.9%

1Y

-21.2%

3Y

-47.7%

5Y

-44.9%

All

-44.6%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DILTIAZEM 12HR ER 120 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 12HR ER 120 MG CAP, manufactured by Glenmark Pharmaceuticals Inc., USA, is $1.9794 per EA (NDC 68462056201), effective Aug 19, 2026.

How has the price of DILTIAZEM 12HR ER 120 MG CAP changed over time?

Over the history we have for it, the NADAC for DILTIAZEM 12HR ER 120 MG CAP has declined 44.6%. It has been tracked across 280 weekly CMS publications since Apr 14, 2021.

What are the highest and lowest recorded NADAC prices for DILTIAZEM 12HR ER 120 MG CAP?

Since Apr 14, 2021, the NADAC for DILTIAZEM 12HR ER 120 MG CAP has ranged from a low of $1.4219 (Jul 17, 2024) to a high of $3.9505 (Sep 13, 2023), with a median of $3.0526 per EA.

Are there cheaper alternatives to DILTIAZEM 12HR ER 120 MG CAP?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DILTIAZEM 24HR ER 120 MG CAP, is $0.0903 per EA — about 95% below DILTIAZEM 12HR ER 120 MG CAP.

Who manufactures DILTIAZEM 12HR ER 120 MG CAP?

DILTIAZEM 12HR ER 120 MG CAP (NDC 68462056201) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.